Mail-Back Envelopes Will Be Dispensed With Outpatient Opioid Scripts
The FDA will require manufacturers of opioid drugs that are dispensed in outpatient settings to provide prepaid mail-back envelopes to outpatient pharmacies and other dispensers, the agency announced Monday. The move is part of the FDA’s comprehensive approach to addressing the overdose crisis, according to FDA Commissioner Robert Califf, MD. “We believe these efforts will […]
Opinion | Are Omicron-Targeted Boosters Worth It?
The FDA, following the advice of its advisory committee, is advising COVID-19 vaccine manufacturers to reformulate future booster shots to include protection against the BA.4 and BA.5 Omicron variants of SARS-CoV-2. While this decision was not surprising and may have seemed perfunctory to many people, it is worth thinking about the wider context that undergirds […]